XWELL, Inc. to Report Fiscal Year 2023 Financial Results on Tuesday, April 16, 2024GlobeNewsWire • Tuesday
CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and ChicagoPRNewsWire • 03/12/24
XWELL Appoints Veteran Consumer & Wellness Entrepreneur Gaëlle Wizenberg to its Board of DirectorsGlobeNewsWire • 12/15/23
Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known PathogensPRNewsWire • 11/06/23
XWELL's CEO Scott Milford Discusses Strategic Growth Plans During Recent Investor Fireside ChatGlobeNewsWire • 10/09/23
XWELL Celebrates Breast Cancer Awareness Month with Philanthropic Nail Care ProgramGlobeNewsWire • 10/02/23
XWELL's CEO Scheduled to Present at Upcoming Investor Fireside Chat on October 4, 2023GlobeNewsWire • 09/28/23
XWELL Grows Footprint Outside the Airport with Acquisition of Naples Wax CenterGlobeNewsWire • 09/12/23
XWELL Extends Collaboration with Centers for Disease Control and Prevention's Traveler-Based Genomic Surveillance ProgramGlobeNewsWire • 08/17/23
XWELL, Inc. to Announce Second Quarter 2023 Financial Results on Monday, August 14GlobeNewsWire • 08/07/23
XWELL, Inc. to Announce First Quarter 2023 Financial Results on Monday, May 15GlobeNewsWire • 05/11/23